Skip to content

Effect of TrueTear Corneal Surface Imaging

Effect of TrueTear Use on Anterior Corneal Surface Imaging Quality

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03637348
Enrollment
45
Registered
2018-08-20
Start date
2018-08-13
Completion date
2019-07-08
Last updated
2020-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Myopia

Brief summary

This study will evaluate the utility of TrueTear™ to improve anterior corneal surface imaging quality before cataract surgery, refractive lens exchange, or laser refractive surgery.

Detailed description

Corneal imaging will be repeated before and after TrueTear use during a single patient visit. Image quality measures will be compared.

Interventions

DEVICETrueTear

Ues of TrueTear neurostimulator

Sponsors

Allergan
CollaboratorINDUSTRY
Price Vision Group
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled to undergo routine imaging for cataract surgery, refractive lens exchange or laser refractive surgery

Exclusion criteria

* A cardiac pacemaker, implanted or wearable defibrillator, or other implanted metallic or electronic device (e.g. cochlear implant) in the head or neck * Chronic or frequent nosebleeds, a bleeding disorder (e.g. hemophilia), or another condition that can lead to increased bleeding * A known hypersensitivity (allergy) to the hydrogel material that comes into contact with the inside of the nose during use of the TrueTearTM device * Pregnancy * Presence of any ocular disease or condition which in the investigator's opinion would confound the study results

Design outcomes

Primary

MeasureTime frameDescription
Surface Asymmetry Index (SAI) Assessed With Corneal TopographyChange from baseline SAI at 5-10 minutes after using the TrueTear device.Surface asymmetry index (SAI) is an index that indicates an average value of the corneal power differences between the points spatially located at 180° from 128 equidistant meridians. A radially symmetrical surface has a value of zero, and this value increases as the degree of asymmetry is greater. Higher values are worse, but there is no set maximum value and no unit of measure.

Secondary

MeasureTime frameDescription
Surface Regularity Index (SRI) Assessed With Corneal TopographyChange from baseline SRI at 5-10 minutes after using the TrueTear device.Surface Regularity index (SRI) is a local descriptor of surface regularity in a central 4.5 mm diameter area of the cornea. It correlates well with the value of visual acuity (p = 0.80, P \<0.001), assuming the cornea is the only limiting factor for vision. A normal cornea presents SRI values below 0.56 (the SRI would be 0 in a perfectly regular cornea). SRI values increase with increasing irregularity of the corneal surface. Higher values are worse, but there is no set maximum value and no unit of measure.

Countries

United States

Participant flow

Participants by arm

ArmCount
TrueTear
Use of TrueTear device to stimulate tear production TrueTear: Ues of TrueTear neurostimulator
45
Total45

Baseline characteristics

CharacteristicTrueTear
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
35 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
Age, Continuous69 years
STANDARD_DEVIATION 10
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
45 Participants
Region of Enrollment
United States
45 participants
Sex: Female, Male
Female
27 Participants
Sex: Female, Male
Male
18 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 45
other
Total, other adverse events
0 / 45
serious
Total, serious adverse events
0 / 45

Outcome results

Primary

Surface Asymmetry Index (SAI) Assessed With Corneal Topography

Surface asymmetry index (SAI) is an index that indicates an average value of the corneal power differences between the points spatially located at 180° from 128 equidistant meridians. A radially symmetrical surface has a value of zero, and this value increases as the degree of asymmetry is greater. Higher values are worse, but there is no set maximum value and no unit of measure.

Time frame: Change from baseline SAI at 5-10 minutes after using the TrueTear device.

ArmMeasureValue (MEAN)Dispersion
TrueTearSurface Asymmetry Index (SAI) Assessed With Corneal Topography0.21 unitlessStandard Deviation 0.34
Secondary

Surface Regularity Index (SRI) Assessed With Corneal Topography

Surface Regularity index (SRI) is a local descriptor of surface regularity in a central 4.5 mm diameter area of the cornea. It correlates well with the value of visual acuity (p = 0.80, P \<0.001), assuming the cornea is the only limiting factor for vision. A normal cornea presents SRI values below 0.56 (the SRI would be 0 in a perfectly regular cornea). SRI values increase with increasing irregularity of the corneal surface. Higher values are worse, but there is no set maximum value and no unit of measure.

Time frame: Change from baseline SRI at 5-10 minutes after using the TrueTear device.

ArmMeasureValue (MEAN)Dispersion
TrueTearSurface Regularity Index (SRI) Assessed With Corneal Topography0.1 unitlessStandard Deviation 0.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026